19
Feb 2015
Share This
0 Comments

‘All we have to do is get it right’

Posted by

An article about the benefits of the Canadian Stem Cell Strategy & Action Plan is featured in the online version of Policy Options, Canada’s premier public policy journal.

Titled ‘How Canada can capitalize on its stem cell technology,’ the piece was written by Dr. Alan Bernstein, President and CEO of the Canadian Institute for Advanced Research and Chair of our Foundation’s Board of Directors, Dr. Allen Eaves, President and CEO of STEMCELL Technologies Inc., and James Price, our Foundation’s President and CEO. It illustrates how Canada can lead the way in stem cell science and translate research into five to 10 new therapies over the next 10 years.

“If we get it right, we can reduce human suffering from chronic, debilitating diseases, ease the burden on an overstressed health care system that is currently costing more than $200 billion a year, boost our economy by creating thousands of new high-skill jobs and own an area of advanced technology that was born in Canada.” said the authors.canada stem cells

“Canada’s role in all of this is vital. We have enormous scientific credibility, given that Canadians virtually founded the field: James Till and Ernest McCulloch proved the existence of stem cells more than 50 years ago at the Princess Margaret Hospital and went on to train and inspire subsequent generations of scientists who have positioned Canada at the leading edge.”

The print version of the article will be available soon in Policy Options, March-April 2015 edition.

Leave a Reply

Your email address will not be published. Required fields are marked *

If you are a human, do not fill out this field